Dr. Le Poole is interested in the ability of melanotoxic agents to target congenital nevus cells. For proof of concept, her group is using in vitro and in vivo models of large congenital nevi, part of an overall interest in benign and malignant pigment cells. Loyola University, Chicago, Illinois, U.S.A.
